跳至主要内容
临床试验/2024-513538-40-02
2024-513538-40-02招募中2 期

Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis.

Amsterdam UMC Stichting, ZonMw3 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月9日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
3
主要终点
Sensitivity

研究概览

简要总结

To determine the efficacy and measurement properties (sensitivity, specificity, positive and negative predictive value) of whole-body [18F]PEG-Folate PET (with ≥1 PET positive joint regarded as positive PET scan) for development of clinical arthritis (in at least 1 joint) in ACPA positive arthralgia individuals during one year follow-up.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Patients must be 18 years of age or older.
  • Patients must be diagnosed with arthralgia (not secondary to trauma) by a physician.
  • Patients must have a positive ACPA blood test, determined as a value of 10 U/mL or higher.
  • Patients must be able to adhere to the study appointments and other protocol requirements.
  • Patients must be capable of giving informed consent and the consent must have been obtained prior to the study related procedures.

排除标准

  • Arthritis and/or tenosynovitis as revealed by physical examination of 44 joints through the Disease Activity Score (DAS) (27) by 2 independent physicians.
  • Previous corticosteroid injection in joints.
  • Trauma involving joints in the 6 months prior to inclusion
  • Pregnancy or breast-feeding.
  • Low risk score at developing RA as calculated by a previously investigated clinical prediction rule.

结局指标

主要结局

Sensitivity

Sensitivity

Specificity

Specificity

Positive predictive value

Positive predictive value

Negative predictive value

Negative predictive value

次要结局

  • Relationship of PET positivity and time to development of clinical arthritis.
  • Cut-off value(s) for this/these specific outcome measure(s) in relation todevelopment of RA within one year.

研究者

发起方
Amsterdam UMC Stichting, ZonMw
申办方类型
Hospital/Clinic/Other health care facility, Health care
责任方
Principal Investigator
主要研究者

Principal investigator

Scientific

Amsterdam UMC Stichting

研究点 (3)

Loading locations...

相似试验